Hiddink, designated MEDIPOST Cord Blood Honorary Ambassador

Korean stem cells regenerate coach Hiddink’s worn-out knee cartilage

MEDIPOST will set up a joint venture company in China

43% Increase in Dosage of CARTISTEM, for 4th Quarter of 2014 Year on Year

Nikkei Japan Reports the Status of MEDIPOST’s Stem Cell Research

Accumulated Dosage of CARTISTEM Exceeds 2,000 Cases

Participation in Biotec Japan and local publicity activities on CARTISTEM

U.S. ABC News gave intensified coverage on ‘CARTISTEM’

‘CARTISTEM’ injection to U.S. clinical trial subject completed

‘CARTISTEM’ shows superb results from 3 year long term tracking clinical trials

US ‘Stem cells regenerative medicine congress’ invites MEDIPOST for the first time as a Korean company

MEDIPOST announced extension plans in US ’2015 Stem Cell Meeting on the Mesa’